Literature DB >> 29406999

Serum cholecalciferol may be a better marker of vitamin D status than 25-hydroxyvitamin D.

Rolf Jorde1, G Grimnes2.   

Abstract

Vitamin D is produced in the skin upon sun-exposure or obtained through the diet. Vitamin D is hydroxylated to 25-hydroxyvitamin D (25(OH)D) in the liver and to the active form 1,25-dihydroxyvitamin D (1,25(OH)2D) in the kidneys. To exert its effect 1,25(OH)2D has to bind to the nuclear vitamin D receptor VDR. Lack of vitamin D leads to rickets in children and to osteomalacia in adults. 25(OH)D is used as a marker of a subject's vitamin D status. Low serum 25(OH)D levels are associated with a number of diseases, risk factors for disease and increased mortality. However, intervention studies with vitamin D have generally been disappointing. Many, if not most cells have the hydroxylases necessary for intra-cellular activation of vitamin D. It is likely that more vitamin D diffuses or are transported into the cells than 25(OH)D and 1,25(OH)2D, and accordingly, most of the 1,25(OH)2D that bind to the VDR are derived from intra-cellular hydroxylation of vitamin D. Therefore, our hypothesis is that serum vitamin D is a better marker of a subject's vitamin D status than 25(OH)D. Since the half-life in serum for vitamin D is approximately one day, giving vitamin D weekly or monthly will result in short-lived serum vitamin D peaks with periods of vitamin D deficiency in between. On the other hand, serum 25(OH)D, which has a half-life of weeks, will show high and stable serum levels throughout. Important vitamin D effects may have been missed in studies with intermittent dosing, and vitamin D in intervention trials should be given daily. Likewise, in epidemiological studies and clinical practice 25(OH)D has uniformly been used as marker. This may lead to gross misclassification of individuals that do not have a stable influx of vitamin D from sun-exposure or diet. In epidemiological studies serum vitamin D should be measured as well as 25(OH)D, and in clinical practice a 25(OH)D measurement should be interpreted in view of recent sun-exposure and diet history.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29406999     DOI: 10.1016/j.mehy.2017.12.017

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  16 in total

1.  Tracking of serum 25-hydroxyvitamin D during 21 years.

Authors:  Julia Kubiak; Elena Kamycheva; Rolf Jorde
Journal:  Eur J Clin Nutr       Date:  2020-12-11       Impact factor: 4.016

Review 2.  Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper.

Authors:  Stefan Pilz; Winfried März; Kevin D Cashman; Mairead E Kiely; Susan J Whiting; Michael F Holick; William B Grant; Pawel Pludowski; Mickael Hiligsmann; Christian Trummer; Verena Schwetz; Elisabeth Lerchbaum; Marlene Pandis; Andreas Tomaschitz; Martin R Grübler; Martin Gaksch; Nicolas Verheyen; Bruce W Hollis; Lars Rejnmark; Spyridon N Karras; Andreas Hahn; Heike A Bischoff-Ferrari; Jörg Reichrath; Rolf Jorde; Ibrahim Elmadfa; Reinhold Vieth; Robert Scragg; Mona S Calvo; Natasja M van Schoor; Roger Bouillon; Paul Lips; Suvi T Itkonen; Adrian R Martineau; Christel Lamberg-Allardt; Armin Zittermann
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-17       Impact factor: 5.555

3.  A randomized placebo-controlled trial of vitamin D supplementation for reduction of mortality and cancer: Statistical analysis plan for the D-Health Trial.

Authors:  Mary Waterhouse; Dallas R English; Bruce K Armstrong; Catherine Baxter; Briony Duarte Romero; Peter R Ebeling; Gunter Hartel; Michael G Kimlin; Donald S A McLeod; Rachel L O'Connell; Jolieke C van der Pols; Alison J Venn; Penelope M Webb; David C Whiteman; Rachel E Neale
Journal:  Contemp Clin Trials Commun       Date:  2019-02-20

4.  No improvement in depressive symptoms by vitamin D supplementation: results from a randomised controlled trial.

Authors:  Rolf Jorde; Julia Kubiak
Journal:  J Nutr Sci       Date:  2018-11-22

Review 5.  The Role of Vitamin D Binding Protein, Total and Free 25-Hydroxyvitamin D in Diabetes.

Authors:  Rolf Jorde
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-19       Impact factor: 5.555

6.  Effectiveness and safety of steady versus intermittent high dose vitamin D supplementation for the prevention of falls and fractures among adults: a protocol for systematic review and network meta-analysis.

Authors:  Banaz Al-Khalidi; Joycelyne Efua Ewusie; Jemila Hamid; Samantha Kimball
Journal:  BMJ Open       Date:  2019-08-20       Impact factor: 2.692

Review 7.  Emerging Evidence of Thresholds for Beneficial Effects from Vitamin D Supplementation.

Authors:  Robert Scragg
Journal:  Nutrients       Date:  2018-05-03       Impact factor: 5.717

Review 8.  Role of Vitamin D in Preventing and Treating Selected Extraskeletal Diseases-An Umbrella Review.

Authors:  Friederike Maretzke; Angela Bechthold; Sarah Egert; Jana B Ernst; Debora Melo van Lent; Stefan Pilz; Jörg Reichrath; Gabriele I Stangl; Peter Stehle; Dorothee Volkert; Michael Wagner; Julia Waizenegger; Armin Zittermann; Jakob Linseisen
Journal:  Nutrients       Date:  2020-03-31       Impact factor: 5.717

9.  Markers Indicating Body Vitamin D Stores and Responses of Liver and Adipose Tissues to Changes in Vitamin D Intake in Male Mice.

Authors:  Mikis Kiourtzidis; Julia Kühn; Corinna Brandsch; Anja-Christina Baur; Monika Wensch-Dorendorf; Gabriele I Stangl
Journal:  Nutrients       Date:  2020-05-13       Impact factor: 5.717

10.  Vitamin D supplementation does not improve CVD risk factors in vitamin D-insufficient subjects.

Authors:  Julia Kubiak; Per Medbøe Thorsby; Elena Kamycheva; Rolf Jorde
Journal:  Endocr Connect       Date:  2018-05-15       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.